Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer
Clinical trial NCT02712723 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02712723
- Sponsor
- Qamar Khan
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2018-08-27
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.